AlerisLife Inc. (ALR)
NASDAQ: ALR · IEX Real-Time Price · USD
1.32
0.00 (0.00%)
Mar 17, 2023, 12:00 AM EDT - Market open
AlerisLife Market Cap
AlerisLife has a market cap or net worth of $44.18 million as of March 20, 2023. Its market cap has decreased by -49.43% in one year.
Market Cap
44.18M
Enterprise Value
8.98M
1-Year Change
-49.43%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since December 17, 2001, AlerisLife Inc.'s market cap has decreased from $2.50B to $44.18M, a decrease of -98.24%. That is a compound annual growth rate of -17.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2023 | 44.18M | 0.76% |
| Mar 16, 2023 | 43.84M | 0.77% |
| Mar 15, 2023 | 43.51M | - |
| Mar 14, 2023 | 43.51M | - |
| Mar 13, 2023 | 43.51M | -0.76% |
| Mar 10, 2023 | 43.84M | -0.76% |
| Mar 9, 2023 | 44.18M | - |
| Mar 8, 2023 | 44.18M | 0.76% |
| Mar 7, 2023 | 43.84M | -0.76% |
| Mar 6, 2023 | 44.18M | - |
| Mar 3, 2023 | 44.18M | 0.76% |
| Mar 2, 2023 | 43.84M | - |
| Mar 1, 2023 | 43.84M | -1.50% |
| Feb 28, 2023 | 44.51M | -0.75% |
| Feb 27, 2023 | 44.84M | 2.29% |
| Feb 24, 2023 | 43.84M | - |
| Feb 23, 2023 | 43.84M | -0.76% |
| Feb 22, 2023 | 44.18M | -0.75% |
| Feb 21, 2023 | 44.51M | -0.75% |
| Feb 17, 2023 | 44.84M | 3.08% |
| Feb 16, 2023 | 43.51M | 0.39% |
| Feb 15, 2023 | 43.34M | - |
| Feb 14, 2023 | 43.34M | -0.38% |
| Feb 13, 2023 | 43.51M | -0.76% |
| Feb 10, 2023 | 43.84M | - |
View and export this data all the way back to 2001.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocuphire Pharma, Inc. | 78.44M |
| Spero Therapeutics, Inc. | 70.42M |
| IN8bio, Inc. | 28.67M |
| Neoleukin Therapeutics, Inc. | 27.62M |
| Frequency Therapeutics, Inc. | 19.55M |
| Cocrystal Pharma, Inc. | 15.06M |
| Iterum Therapeutics plc | 13.21M |
| Aptorum Group Limited | 8.66M |
| Aileron Therapeutics, Inc. | 6.36M |